Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Por Biersack Hans-Jürgen, Wilinek Winfried, Herrlinger Ulrich, Ahmadzadehfar Hojjat, Sabet Amir, Ezziddin Samer
Publicado em 2011-08-01

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Por Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Publicado em 2011

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG

Por Ezziddin, Samer, Sabet, Amir, Ko, Yon-Dschun, Xun, Sunny, Matthies, Alexander, Biersack, Hans-Jürgen
Publicado em 2012

May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

Por Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Publicado em 2013

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

Por Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Publicado em 2013

Efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

Por Sabet, Amir, Haug, Alexander R, Eiden, Collin, Auernhammer, Christoph J, Simon, Birgit, Bartenstein, Peter, Biersack, Hans J, Ezziddin, Samer
Publicado no Am J Nucl Med Mol Imaging (2017)

Quantitative performance of (124)I PET/MR of neck lesions in thyroid cancer patients using (124)I PET/CT as reference

Por Jentzen, Walter, Phaosricharoen, Jinda, Gomez, Benedikt, Hetkamp, Philipp, Stebner, Vanessa, Binse, Ina, Kinner, Sonja, Herrmann, Ken, Sabet, Amir, Nagarajah, James
Publicado no EJNMMI Phys (2018)

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

Por Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Publicado em 2013

Hematologic safety of (177)Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Por Groener, Daniel, Nguyen, Cam Tu, Baumgarten, Justus, Bockisch, Benjamin, Davis, Karen, Happel, Christian, Mader, Nicolai, Nguyen Ngoc, Christina, Wichert, Jennifer, Banek, Severine, Mandel, Philipp, Chun, Felix K. H., Tselis, Nikolaos, Grünwald, Frank, Sabet, Amir
Publicado no EJNMMI Res (2021)